Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (21-30 of 282) with videos related to

Pageof 29
Sort By:
European Journal of Immunology|September 1, 1983
The immune response against anti-idiotope antibodies II. The induction of antibodies bearing the target idiotope (Ab3 beta) depends on the frequency of the corresponding B cellsH Tesch, T Takemori, K Rajewsky
Advances in Experimental Medicine and Biology|January 1, 1979
Generation of an eosinophilotactic factor from human PMNS by various mechanisms of cell activationW König, N Frickhofen, H Tesch
Immunology|April 1, 1979
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activationW König, N Frickhofen, H Tesch
Praxis|March 19, 1996
[Clinical aspects and primary therapy of Hodgkin's lymphomas]M Sieber, H Tesch, V Diehl
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Treatment of intermediate stagesH Tesch, M Sieber, V Diehl
In Vivo (Athens, Greece)|May 1, 1991
Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemiaH Tesch, C Fonatsch, V Diehl
Frontiers in Pharmacology|June 15, 2017
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac FibrosisGreg H Tesch, Morag J Young
International Archives of Allergy and Applied Immunology|January 1, 1979
Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acidH Tesch, W König, N Frickhofen
European Journal of Immunology|June 1, 1978
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acidW König, H Tesch, N Frickhofen
Der Internist|February 1, 1993
[Cellular and molecular biology of malignant lymphoma]H Tesch, H Stein, V Diehl
Pageof 29

Showing results (21-30 of 282) with videos related to

Sort By:
Pageof 29
European Journal of Immunology|September 1, 1983
The immune response against anti-idiotope antibodies II. The induction of antibodies bearing the target idiotope (Ab3 beta) depends on the frequency of the corresponding B cellsH Tesch, T Takemori, K Rajewsky
Advances in Experimental Medicine and Biology|January 1, 1979
Generation of an eosinophilotactic factor from human PMNS by various mechanisms of cell activationW König, N Frickhofen, H Tesch
Immunology|April 1, 1979
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activationW König, N Frickhofen, H Tesch
Praxis|March 19, 1996
[Clinical aspects and primary therapy of Hodgkin's lymphomas]M Sieber, H Tesch, V Diehl
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Treatment of intermediate stagesH Tesch, M Sieber, V Diehl
In Vivo (Athens, Greece)|May 1, 1991
Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemiaH Tesch, C Fonatsch, V Diehl
Frontiers in Pharmacology|June 15, 2017
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac FibrosisGreg H Tesch, Morag J Young
International Archives of Allergy and Applied Immunology|January 1, 1979
Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acidH Tesch, W König, N Frickhofen
European Journal of Immunology|June 1, 1978
Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acidW König, H Tesch, N Frickhofen
Der Internist|February 1, 1993
[Cellular and molecular biology of malignant lymphoma]H Tesch, H Stein, V Diehl
Pageof 29